BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia’s CardiAMP Cell Therapy Chronic Myocardial Ischemia Trial Results Show Patient Benefits in Important Outcomes
01 mai 2024 07h00 HE | BioCardia, Inc.
SUNNYVALE, Calif., May 01, 2024 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases,...
BioCardia-Final-Logo-2016-JPEG.jpg
BioCardia Reports Positive Interim Results from Phase III CardiAMP Cell Therapy Heart Failure Trial, with Compelling Data in Subgroup with Elevated NTproBNP Biomarker for Heart Failure
04 mars 2024 08h00 HE | BioCardia, Inc.
CardiAMP cell therapy-treated patients had 37% relative risk reduction in heart death equivalent (death, heart transplant, left ventricular assist device implantation) and 9% relative risk reduction...
sema.jpg
Semantix Announces 3Q 2023 Financial Results
08 nov. 2023 07h08 HE | Semantix, Inc.
Semantix Announces 3Q 2023 Financial Results
sema.jpg
Semantix Announces Date of Third Quarter 2023 Financial Results
30 oct. 2023 08h58 HE | Semantix, Inc.
SÃO PAULO, Brazil, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX), a leading Latin American enterprise AI platform and applications provider, today announced it will release...
sema.jpg
Semantix Announces Date of Second Quarter 2023 Financial Results
08 août 2023 08h37 HE | Semantix, Inc.
SÃO PAULO, Brazil, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX), a leading Latin American enterprise AI platform and applications provider, today announced it will release...
EQUASENS  : résultat
EQUASENS : résultat du vote des résolutions présentées à l’assemblée générale ordinaire annuelle du 29 juin 2023
05 juil. 2023 12h00 HE | EQUASENS
Villers-lès-Nancy, le 5 juillet 2023 – 18:00 (CET) COMMUNIQUE DE PRESSE RESULTAT DU VOTE DES RESOLUTIONS PRESENTEES A L’ASSEMBLEE GENERALE ORDINAIRE ANNUELLE DU 29 JUIN 2023 Nombre d’actions...
EQUASENS_EN.png
EQUASENS: results of the votes on the resolutions submitted to the ordinary annual shareholders' meeting of 29 june 2023
05 juil. 2023 12h00 HE | EQUASENS
Villers-lès-Nancy, 5 July 2023 - 6:00 p.m. (CET) PRESS RELEASE RESULTS OF THE VOTES ON THE RESOLUTIONS SUBMITTED TO THE ORDINARY ANNUAL SHAREHOLDERS' MEETING OF 29 JUNE 2023 Number of shares...
Staffing360_Logo_Primary.jpg
Staffing 360 Solutions Reports Second Quarter and Six-Month 2022 Results
23 août 2022 16h10 HE | Staffing 360 Solutions, Inc.
NEW YORK, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build strategy through the acquisition of staffing...
Staffing360_Logo_Primary.jpg
Staffing 360 Solutions Reports Fiscal Full Year 2021 Financial Results
27 juin 2022 08h36 HE | Staffing 360 Solutions, Inc.
Schedules Conference Call for June 30, 2022 NEW YORK, June 27, 2022 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build...
Staffing360_Logo_Primary.jpg
Staffing 360 Solutions Reports Improved Fiscal Third Quarter and Nine-Month Results
15 nov. 2021 16h46 HE | Staffing 360 Solutions, Inc.
Positive Income from Operations, Net Income and Basic EPS in Q3 NEW YORK, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international...